UNH · NYSE
UnitedHealth Group provides health coverage and healthcare services. Its UnitedHealthcare business sells insurance and benefits coverage, while Optum supplies healthcare, pharmacy and related services; the evidence specifically highlights Optum momentum and the company’s diversified platform. UnitedHealth serves more than 48.5 million people and generated $447.6 billion of revenue and $12.1 billion of net income in FY2025, compared with $400.3 billion of revenue and $14.4 billion of net income in FY2024. The supplied material does not quantify the revenue contribution of UnitedHealthcare versus Optum, but it identifies both as core parts of the business.
UNH fell $21.24, or 4.95%, across the provided trading sequence, from $428.79 to $407.55. The stock dropped to $420.57 in the first session, briefly recovered to $421.47, then resumed its decline through $414.40 and $407.55, with the final selloff accompanied by volume rising to 5.27 million shares. The supplied evidence does not identify a company-specific announcement that explains the move. Recent commentary was broadly constructive on UnitedHealth’s cost controls, lower medical costs and 2026 outlook, but the shares nevertheless weakened. The broader context included investor concern over AI-stock volatility, upcoming U.S. jobs data, Middle East tensions and an Indian rate decision.
The Zacks Analyst Blog Highlights SpaceX, United Health, The Goldman Sachs and Industrial and Commercial Bank
See Which Recent 13F Filers Hold UNH
CVS Health's Q2 Earnings on Deck: How Should You Play the Stock?
UnitedHealth vs. Centene: Which Managed Care Stock Is the Better Buy?Wall Street Analysts Think UnitedHealth (UNH) Is a Good Investment: Is It?Warren Buffett's Legacy Oil Bet Is Paying Off Under Greg Abel. Nobody's Talking About It.Teladoc Health Q2 Earnings Beat Estimates on Integrated Care Strength